Second Hospital of Tianjin Medical University
In research, Second Hospital of Tianjin Medical University stands highest in Life Sciences (#2,819 of 7,800 worldwide), Medicine (#3,936 of 10,443 worldwide) and Health Sciences (#5,261 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology — Cardiology and Cardiovascular Medicine is 8.9× its share of world research.
- World rank, 2022–2025
- #6,416 of 28,054 · #12,133 all time
- Rank in China
- #1,340 of 3,058
- Research works
- 1.9k ▲ 9% vs 2013–17
- Citations
- 18k 9.5 per fractional work
- Top-10% rate
- 19.7% record average 16.5%
- Open access
- 40% world 28%
What is Second Hospital of Tianjin Medical University known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #2,819 of 7,800 | 22.8% | 123 | #5404 | |
| MedicineField | #3,936 of 10,443 | 17.8% | 314 | #5933 | |
| Health SciencesDomain | #5,261 of 11,982 | 17.9% | 324 | #7705 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,347 of 3,579 | 22.6% | 94 | #4622 |
Each strip is that field’s whole ranked pool, with the notch where Second Hospital of Tianjin Medical University sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#5,404 #2,819
- Medicine#5,933 #3,936
- Health Sciences#7,705 #5,261
- Biochemistry, Genetics and Molecular Biology#4,622 #2,347
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Second Hospital of Tianjin Medical University specialise in?
Where its research is concentrated relative to its size: Cardiology and Cardiovascular Medicine takes 8.9× the share of its output that it takes of world research.
- Cardiology and Cardiovascular MedicineSubfield · 46.0 works8.9×
- Pulmonary and Respiratory MedicineSubfield · 52.7 works6.9×
- OncologySubfield · 26.6 works4.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.5×
- Medicine 3.3×
- Immunology and Microbiology 3.3×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Dentistry 1.3×
- Neuroscience 1.2×
- Nursing 0.9×
- Materials Science 0.6×
- Health Professions 0.3×
- Environmental Science 0.3×
- Chemical Engineering 0.3×
- Chemistry 0.2×
- Engineering 0.2×
- Energy 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.1×
- Arts and Humanities 0.1×
- Physics and Astronomy 0.1×
- Decision Sciences 0.1×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.0×
- Social Sciences 0.0×
Which keywords describe research at Second Hospital of Tianjin Medical University?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Immunotherapy, Tumor Microenvironment, Oxidative Stress, Cardiovascular Disease, Gene Expression and Biomarkers.
- Epigenetic Regulation
- Bladder Cancer
- Myocardial Infarction
- Biogenesis
- Chronic Kidney Disease
- Atherosclerosis
- Prostate Cancer
- Ferroptosis
- Lipid Peroxidation
- Clinical Guidelines
- Obesity
- Genetic Mutations
- Risk Factors
- Heart Failure
- Metabolic Syndrome
- Gene Expression
- Treatment
- Tumor Microenvironment
- Oxidative Stress
- Inflammation
- Cancer
- Epidemiology
- Immunotherapy
- Cardiovascular Disease
- Biomarkers
- Guidelines
- Chemotherapy
- Cell Death
- Diagnosis
- Management
- Molecular Characterization
- Clinical Trials
- Cancer Therapy
- GPX4
- Metastasis
- Neoadjuvant Therapy
- Prognostic Factors
- Echocardiography
- Angiogenesis
- Urothelial Carcinoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer52▲ 7.8×42 topics
- Inflammation46▲ 4.5×70 topics
- Epidemiology39▲ 2.0×81 topics
- Oxidative Stress35▲ 4.3×45 topics
- Immunotherapy31▲ 8.9×16 topics
- Tumor Microenvironment31▲ 14×8 topics
- Cardiovascular Disease30▲ 5.5×31 topics
- Treatment24▲ 4.1×35 topics
- Biomarkers24▲ 7.0×15 topics
- Gene Expression23▲ 7.8×10 topics
- Guidelines22▲ 9.5×11 topics
- Metabolic Syndrome22▲ 5.4×19 topics
- Chemotherapy19▲ 5.6×18 topics
- Heart Failure17▲ 8.0×13 topics
- Cell Death17▲ 15×6 topics
- Risk Factors17▲ 3.1×20 topics
- Diagnosis16▲ 3.6×29 topics
- Genetic Mutations16▲ 7.7×16 topics
- Management16▲ 4.1×20 topics
- Obesity16▲ 4.2×19 topics
- Molecular Characterization16▲ 18×4 topics
- Clinical Guidelines13▲ 8.9×7 topics
- Clinical Trials13▲ 3.9×12 topics
- Lipid Peroxidation13▲ 25×2 topics
- Cancer Therapy13▲ 4.5×17 topics
- Ferroptosis12▲ 33×1 topic
- GPX412▲ 33×1 topic
- Prostate Cancer12▲ 19×5 topics
- Metastasis12▲ 7.1×10 topics
- Atherosclerosis12▲ 8.4×11 topics
- Neoadjuvant Therapy12▲ 10×5 topics
- Chronic Kidney Disease11▲ 9.1×7 topics
- Prognostic Factors11▲ 5.0×14 topics
- Biogenesis11▲ 12×3 topics
- Echocardiography11▲ 7.9×7 topics
- Myocardial Infarction10▲ 8.8×6 topics
- Angiogenesis10▲ 6.1×15 topics
- Bladder Cancer9▲ 51×1 topic
- Urothelial Carcinoma9▲ 44×1 topic
- Epigenetic Regulation9▲ 8.5×4 topics
Which research topics does Second Hospital of Tianjin Medical University publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers and Prostate Cancer Treatment and Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 12 works
- 2 Bladder and Urothelial Cancer Treatments Surgery 9 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 8 works
- 4 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 7 works
- 5 Cancer-related molecular mechanisms research Cancer Research 7 works
- 6 Kidney Stones and Urolithiasis Treatments Pulmonary and Respiratory Medicine 6 works
- 7 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 5 works
- 8 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 5 works
- 9 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 5 works
- 10 RNA modifications and cancer Molecular Biology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Second Hospital of Tianjin Medical University's research output changed?
Output in 2018–2022 was 9% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tianjin
- Tianjin University
- Nankai University
- Hebei University of Technology
- Tianjin University of Technology
- Tiangong University
- Tianjin Medical University
- Tianjin University of Science and Technology
- Civil Aviation University of China
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.